The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Immunol.
Sec. Systems Immunology
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1456083
This article is part of the Research Topic Renal Dysfunction in Cardiometabolic Disease: Implications of Inflammation and Oxidative Stress View all articles
Identification of novel biomarkers, shared molecular signatures and immune cell infiltration in heart and kidney failure by transcriptomics
Provisionally accepted- 1 RWTH Aachen University, Aachen, Germany
- 2 University of Stuttgart, Stuttgart, Baden-Württemberg, Germany
- 3 University of Koblenz, Koblenz, Rhineland-Palatinate, Germany
- 4 The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Heart failure (HF) and kidney failure (KF) are closely related conditions that often coexist, posing a complex clinical challenge. Understanding the shared mechanisms between these two conditions is crucial for developing effective therapies. This study aims to unveil the molecular signatures and identify novel biomarkers for both HF and KF. Through transcriptomic analysis, 2869 shared differentially expressed genes (DEGs) were identified in patients with HF and KF compared to healthy controls. Functional enrichment analysis of these genes indicated that the common mechanisms underlying HF and KF are associated with cellular homeostasis, cell communication, cellular replication, inflammation, and extracellular matrix (ECM) production. Notably, the P13K-Akt signaling pathway was primally enriched. A proteinprotein interaction (PPI) network was constructed to characterize the hub genes, revealing two key protein clusters related to the cell cycle and inflammation. Machine learning algorithms, including Random Forest (RF), Support Vector Machine-Recursive Feature Elimination (SVM-RFE), and Least Absolute Shrinkage and Selection Operator (LASSO), identified CDK2 and CCND1 as signature genes for both HF and KF. These genes were further analyzed using Gene Set Variation Analysis (GSVA) and Gene Set Enrichment Analysis (GSEA). Their diagnostic value was validated in both training and validation sets. Additionally, a CDK2 activator was selected to dock with CCND1, and a CCND1 inhibitor was selected to dock with CDK2 to evaluate potential drug candidates, although further cytotoxicity assessments are needed. Immune cell infiltration analysis in HF and KF patients versus healthy controls, along with correlation analyses between various immune cell types and signature genes, revealed that CDK2 and CCND1 are correlated with immune response.Conclusively, this study identifies CDK2 and CCND1 as novel biomarkers that link cell cycle regulation and inflammation in heart and kidney failure. These findings offer new insights into the molecular mechanisms of HF and KF and present potential targets for diagnosis and therapy.
Keywords: Heart Failure, Kidney failure, CDK2, CCND1, Cell Cycle, Inflammation, immunology
Received: 28 Jun 2024; Accepted: 28 Aug 2024.
Copyright: © 2024 Long, Zhang, Ren, Wu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ze-Mu Wang, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.